Breakdown of RNAi-Based Drugs in the Clinic Oct 16, 2008 Premium Save for later click here. File Attachments ClinicChart_101608.htm ClinicChart_101608.htm Filed under Gene Silencing/Gene Editing RNAi Breaking News TwinStrand Biosciences Raises $50M in Series B Round Becton Dickinson Fiscal Q2 Revenues up 15 Percent Bio-Techne Fiscal Q3 Revenues Rise 25 Percent as End Markets Improve OraSure Technologies Q1 Revenues Jump 85 Percent 10x Genomics Q1 Revenues Jump 47 Percent Personalis Q1 Revenues Grow 9 Percent The Scan UK Funds to Stay Ahead of Variants The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports. Push for Access In a letter, researchers in India seek easier access to COVID-19 data, Science reports. Not as Cold Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes. Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.